A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.

@article{BlumePeytavi2012ARD,
  title={A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.},
  author={Ulrike Blume-Peytavi and Sanna L{\"o}nnfors and Kathrin Hillmann and Natalie Garcia Bartels},
  journal={Journal of the American Academy of Dermatology},
  year={2012},
  volume={66 5},
  pages={
          794-800
        }
}
BACKGROUND Latanoprost is a prostaglandin analogue used to treat glaucoma. It can cause adverse effects, such as iridial and periocular hyperpigmentation, and eyelash changes including pigmentation and increased thickness, length, and number. Latanoprost has been used to treat eyelash alopecia, but knowledge on its effects on human scalp hair growth is not available. OBJECTIVE The primary objectives were to assess the efficacy of latanoprost on hair growth and pigmentation. The secondary… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

Hair restoration surgery: challenges and solutions

  • Clinical, cosmetic and investigational dermatology
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Human eyelash characterization.

  • The British journal of dermatology
  • 2010
VIEW 1 EXCERPT

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.

  • Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • 2007
VIEW 1 EXCERPT